Interesting that Retractable Technologies isn't on the list. They have successfully sued BD several times and won for patent infringement. Your comments would be more relevant if BD were licensing the technology. Sanofi isn't paying $55MM for nothing. Not when they are losing marketshare on Lovenox.
